InsidersTradesSigma
申报总数
公司
▲ 买入（3 笔）
▼ 卖出（1 笔）
内部人交易记录
高级管理人员已披露买入
3
已披露卖出
1
T+90 胜率
33%
T+90 平均收益
-9.0%
基于 3 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Browse the full record of transactions filed by Dachille Douglas A., Directeur Informatique. Director active across 4 companies, notably American International Group, INC.. In total, 8 filings have been logged. Split: 3 buys · 1 sell. Total volume traded: €1m. History available since 2 June 2021. The latest transaction was disclosed on 20 May 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Dachille Douglas A.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报8 总计
3,990 股Common StockSEC:0001470831-26-000626:0
4,400 股@ US$42.050.0014% mcap100.0% 占其流量Common StockSEC:0001628280-26-037378:0
6,589 股0Common StockSEC:0000950170-25-089646:0
3,393 股0Common StockSEC:0001628280-25-027595:0
100 股@ US$198.133100.0% 占其流量$5 Par Common StockSEC:0001628280-25-004077:0
标准退出：2025年5月4日 (T+90)
10,000 股@ US$8.193450.2% 占其流量Common StockSEC:0000899243-22-011246:0
标准退出：2022年6月12日 (T+90)
5,000 股@ US$16.8249.8% 占其流量Common StockSEC:0000899243-22-001169:0
标准退出：2022年4月4日 (T+90)
19,712 股@ US$53.2301100.0% 占其流量Common StockSEC:0001225208-21-008998:0
8 条申报中的 8 条
About Dachille Douglas A.
Douglas A. Dachille serves as Executive Vice President and Chief Information Officer at American International Group, Inc. and BridgeBio Pharma, Inc. In this role, he oversees IT operations and ensures that technological systems support the strategic objectives of the companies. His expertise in information technology is essential to foster innovation and efficiency.
